OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
John C. Kraft, Minh N. Pham, Laila Shehata, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100780-100780
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
Magnus A. G. Hoffmann, Zhi Yang, Kathryn E. Huey‐Tubman, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2380-2391.e9
Open Access | Times Cited: 42

Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 40

Growing Glycans in Rosetta: Accurate de novo glycan modeling, density fitting, and rational sequon design
Jared Adolf‐Bryfogle, Jason W. Labonte, John C. Kraft, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 6, pp. e1011895-e1011895
Open Access | Times Cited: 18

Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 15

Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Kwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30

DNA origami vaccines program antigen-focused germinal centers
Anna Romanov, Grant A. Knappe, Larance Ronsard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
Julia Ludwig, S.W. Scally, Giulia Costa, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
Annemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge
Mirte N. Pascha, M. Ballegeer, M. C. Roelofs, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3

Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing
Sonia Bhattacharya, Matthew C. Jenkins, Parisa Keshavarz-Joud, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20083-20100
Open Access | Times Cited: 3

Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17

Chemical and biological conjugation strategies for the development of multivalent protein vaccine nanoparticles
Jaeyoung Park, Thomas Pho, Julie A. Champion
Biopolymers (2023) Vol. 114, Iss. 8
Closed Access | Times Cited: 9

Vaccination Strategies Based on Bacterial Self-Assembling Proteins as Antigen Delivery Nanoscaffolds
Félix Lamontagne, Vinay Khatri, Philippe St‐Louis, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1920-1920
Open Access | Times Cited: 14

De Novo Design of Polyhedral Protein Assemblies: Before and After the AI Revolution
Bhoomika Basu Mallik, Jenna Stanislaw, Tharindu Madhusankha Alawathurage, et al.
ChemBioChem (2023) Vol. 24, Iss. 15
Open Access | Times Cited: 8

Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccines
Alexandra Trkola, Penny L. Moore
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 4, pp. e252-e255
Closed Access | Times Cited: 8

Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge in mice
Mirte N. Pascha, Marlies Ballegeer, Marc C. Roelofs, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Self-Assembled Protein Vesicles as Vaccine Delivery Platform to Enhance Antigen-Specific Immune Responses
Yirui Li, Julie A. Champion
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies
Kegomoditswe Malebo, Jeremy Woodward, Phindile Ximba, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1063-1063
Open Access | Times Cited: 1

Self-assembled protein vesicles as vaccine delivery platform to enhance antigen-specific immune responses
Yirui Li, Mariela R. Rodriguez-Otero, Julie A. Champion
Biomaterials (2024) Vol. 311, pp. 122666-122666
Open Access | Times Cited: 1

ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses
Magnus A. G. Hoffmann, Zhi Yang, Kathryn E. Huey‐Tubman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6

Preclinical developments in the delivery of protein antigens for vaccination
Dylan A. Hendy, Alex Haven, Eric M. Bachelder, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 3, pp. 367-384
Open Access | Times Cited: 3

Multiplex miRNA reporting platform for real-time profiling of living cells
Yaxin Hu, Cheuk Yin Li, Qiuyu Lu, et al.
Cell chemical biology (2023) Vol. 31, Iss. 1, pp. 150-162.e7
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top